SNORA2B: A Protein Involved in Brain Function and Psychiatric Disorders

Target Name: SNORA2B

NCBI ID: G677794

SNORA2B

Other Name(s): ACA2b | small nucleolar RNA, H/ACA box 2B | Small nucleolar RNA, H/ACA box 2B

SNORA2B: A Protein Involved in Brain Function and Psychiatric Disorders

SNORA2B (ACA2b) is a protein that is expressed in many tissues throughout the body. It is a member of the ACA2 family of proteins, which are involved in the regulation of cell adhesion and migration. SNORA2B is unique because it is highly expressed in the brain, and it is involved in the formation of axons, which are the long, thread-like structures that carry nerve signals away from the brain.

Recent studies have suggested that SNORA2B may be a drug target or biomarker for a variety of neurological and psychiatric disorders. For example, some researchers have found that individuals with schizophrenia and other psychiatric disorders have lower levels of SNORA2B in their brains than healthy individuals. Other studies have also shown thatSNORA2B is involved in the development and progression of neurodegenerative diseases, such as Alzheimer's and Parkinson's disease.

One of the potential benefits of targeting SNORA2B is that it is thought to play a role in the regulation of brain function and the maintenance of normal brain structure. It is involved in the formation of axons, which are critical for the transmission of nerve signals. It is also involved in the regulation of cell proliferation and differentiation, which are important for the development and maintenance of neural networks.

In addition, SNORA2B may also be a good biomarker for certain psychiatric disorders. Studies have shown that SNORA2B levels are often lower in individuals with major depressive disorder and other psychiatric disorders than in healthy individuals. This suggests that SNORA2B may be a useful target for the development of new treatments for these disorders.

Another potential benefit of targeting SNORA2B is that it is thought to be involved in the regulation of pain. Studies have shown that SNORA2B is involved in the regulation of pain perception and the development of pain-related conditions. This suggests that SNORA2B may be a useful target for the development of new treatments for pain.

Overall, SNORA2B is a protein that is involved in a variety of important processes in the brain. It is a potential drug target and biomarker for a variety of psychiatric and neurological disorders. Further research is needed to fully understand the role of SNORA2B in these processes and to develop new treatments based on this protein.

Protein Name: Small Nucleolar RNA, H/ACA Box 2B

The "SNORA2B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORA2B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets